InsiderTrades

Form 4 for OGN Organon & Co.

Accepted 2022-02-10 00:00:00 ET · period of report 2022-02-09 · accession 0000899243-22-005697 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-10 2022-02-09 OGN DiMarco Kathryn Corp. Ctrl M - OptEx $0.00 +1,869 2,672 +233% $0
D 2022-02-10 2022-02-09 OGN DiMarco Kathryn Corp. Ctrl F - Tax $33.75 -745 1,927 -28% -$25.1K
D 2022-02-10 2022-02-09 OGN DiMarco Kathryn Corp. Ctrl M - OptEx $0.00 -1,869 3,740 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-09 M A 1,869 $0.00 2,672 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock.
2 Common Common Stock 2022-02-09 F D 745 $33.75 1,927 D — —
3 Derivative Restricted Stock Units 2022-02-09 M D 1,869 $0.00 3,740 D — · 2022-02-09 to 2024-02-09 1,869 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock. (F2) On June 2, 2021 in connection with the separation of Organon from Merck & Co., Inc., the restricted stock unit award was converted into a restricted stock unit award with 5,609 shares of Organon common stock underlying such award. These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments. The first installment vested and has been distributed on February 9, 2022. The remaining installments will vest and be distributed on each of February 9, 2023 and February 9, 2024.